M. Yldau van der Ende, Minke H. T. Hartman, Yanick Hagemeijer, Laura M

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.
Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands Annemarie C. de Vries, Nicole C.T. van.
The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease Ilja M. Blok, Annelieke C.M.J. van.
Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population  Sharmini Selvarajah, Gurpreet.
Volume 4, Pages (September 2014)
Volume 20, Issue 7, Pages (July 2017)
The obesity paradox in men with coronary heart disease and heart failure: The role of muscle mass and leptin  S. Goya Wannamethee, A. Gerald Shaper, Peter.
The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replacement or total knee replacement.
Volume 51, Issue 2, Pages (February 2007)
Hemoglobin levels and new-onset heart failure in the community
Remko Kockelkoren, Pushpa M Jairam, John T. Murchison, Thomas P. A
S.E. Knapen, M. van de Werken, M.C.M. Gordijn, Y. Meesters 
Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis  Sarah A. Anderson, John.
Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies  Xia Wang, Yingying.
Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: Data from the prospective Second Manifestations of ARTerial.
Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure  Eline L. Vegter, Daniela Schmitter, Yanick.
Erik O. Udo, Norbert M. van Hemel, Nicolaas P. A
Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations  Judith A. Finegold,
M. Yldau van der Ende, Minke H. T. Hartman, Yanick Hagemeijer, Laura M
Trends in comorbidity in patients hospitalised for cardiovascular disease  Josefien Buddeke, Michiel L. Bots, Ineke van Dis, Anho Liem, Frank L.J. Visseren,
The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replacement or total knee replacement.
Coronary computed tomography versus exercise testing in patients with stable chest pain: comparative effectiveness and costs  Tessa S.S. Genders, Bart.
Impact of non-cardiovascular disease comorbidity on cardiovascular disease symptom severity: A population-based study  C.A. Rushton, U.T. Kadam  International.
Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Screening for asymptomatic cardiovascular disease with noninvasive imaging in patients at high-risk and low-risk according to the European Guidelines.
Heart failure and inflammation-related biomarkers as predictors of new-onset diabetes in the general population  Navin Suthahar, Wouter C. Meijers, Frank.
Kirolos A. Jacob, Marc P. Buijsrogge, Jos F. Frencken, Maarten J
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical.
Endurance exercise-induced changes in BNP concentrations in cardiovascular patients versus healthy controls  Vincent L. Aengevaeren, Maria T.E. Hopman,
Ronak Delewi, Wieneke Vlastra, Wim J. Rohling, Tineke C
Abnormal heart-rate response during cardiopulmonary exercise testing identifies cardiac dysfunction in symptomatic patients with non-obstructive coronary.
International Journal of Cardiology
Metabolic mediators of body-mass index and cardiovascular risk
2014 Global geographic analysis of mortality from ischaemic heart disease by country, age and income: Statistics from World Health Organisation and United.
Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment  Robert Dufour,
International Journal of Cardiology
Cardiovascular Disease in Women of Reproductive Age
Changing demographics in patients with vascular disease
Are the Institute of Medicine Recommendations for Gestational Weight Gain Appropriate for Adolescents?  Susan Groth, PHD, RNC, NP  Journal of Obstetric,
Patient-reported causes of heart failure in a large European sample
Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population  Sharmini Selvarajah, Gurpreet.
Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012  A.C.E.
Non-adherence to cardiovascular drugs in older patients with depression: A population- based cohort study  Floor Holvast, Hans Wouters, Karin Hek, François.
CPR 1.2.: Evaluation of Anemia in CKD
Support Your Specialty
Cardiovascular health, risks and diseases in contemporary China
Scott B. Capps, MSa, Ronald C. Elkins, MDb, David M. Fronk, MSa 
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease  Tetsuro Tsujimoto, Hiroshi Kajio 
International Journal of Cardiology
Volume 17, Issue 2, Pages (February 1950)
Clinical Epidemiology and Global Health
Higher risk of hospitalization among females with cystic fibrosis
Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery  P.-G. Chassot, A. Delabays, D.R. Spahn 
Reported cardiac phenotypes in hereditary hemorrhagic telangiectasia emphasize burdens from arrhythmias, anemia and its treatments, but suggest reduced.
Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into.
Trends in mortality risks among 94,328 patients surviving 30days after a first isolated coronary artery bypass graft procedure from 1987 to 2006: A population-based.
Population trends and inequalities in incidence and short-term outcome of acute myocardial infarction between 1998 and 2007  Carla Koopman, Michiel L.
The “obesity paradox” in an elderly population with a high prevalence of Chagas disease: The 10-year follow-up of the Bambuí (Brazil) Cohort Study of.
Volume 51, Issue 2, Pages (February 2007)
Timothy J. Gardner, M. D. , Peter J. Horneffer, M. D. , Teri A
The failure of breast cancer screening
International Journal of Cardiology
Discussion The Journal of Thoracic and Cardiovascular Surgery
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation  Finlay A. McAlister,
Presidential address: The second-generation vascular surgeon
Borderline Q-waves in individuals without overt cardiovascular disease: Relations with adiposity, subclinical atherosclerosis and vascular stiffness 
Presentation transcript:

The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors  M. Yldau van der Ende, Minke H.T. Hartman, Yanick Hagemeijer, Laura M.G. Meems, Hendrik Sierd de Vries, Ronald P. Stolk, Rudolf A. de Boer, Anna Sijtsma, Peter van der Meer, Michiel Rienstra, Pim van der Harst  International Journal of Cardiology  Volume 228, Pages 495-500 (February 2017) DOI: 10.1016/j.ijcard.2016.11.061 Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions

Fig. 1 Population distribution in the Netherlands in 2010 and population distribution in the LifeLines Cohort Study population. International Journal of Cardiology 2017 228, 495-500DOI: (10.1016/j.ijcard.2016.11.061) Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions

Fig. 2 Body mass index distribution for males and females in the middle and older age category in the LifeLines Cohort Study, BMI=body mass index. International Journal of Cardiology 2017 228, 495-500DOI: (10.1016/j.ijcard.2016.11.061) Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions

Fig. 3 Mean SCORE and CVD per age category in the LifeLines Cohort Study. SCORE=Systematic Coronary Risk Evaluation Project; CVD=cardiovascular disease. International Journal of Cardiology 2017 228, 495-500DOI: (10.1016/j.ijcard.2016.11.061) Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions